VITEK 2 Gram Negative Ceftriaxone (<=0.25->=64 ug/mL)
510(k) K161217
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK161217 | Date12 Jan 2017 | StatusActive |
Recalls
-
- Ongoing Z-1464-2024
Ceftriaxone (cro02n) concentration errors associated with specific recently manufactured test kits which would have the potential for for false susceptible results. The risk is present for isolates that have a result of MIC=0.5, 1, 2.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LON
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1645
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The VITEK 2 Gram Negative Ceftriaxone is an automated antimicrobial susceptibility test system used to determine the effectiveness of Ceftriaxone against Gram-negative bacteria. The test contains Ceftriaxone concentrations of 0.12, 0.25, 1, 4 and 16 µg/mL with a reporting range of ≤ 0.25 - ≥64 µg/mL.
This device is manufactured by bioMerieux, Inc. and is classified as a Class II medical device under product code LON. It is supplied as a component of the VITEK 2 AST-Gram Negative card and is intended for use in microbiology laboratories. The device received FDA 510(k) clearance with K161217 on January 12, 2017.